Four New Sets of Pre-Clinical Data Further Expands the Evidence Supporting Abelacimab
- Wednesday, July 13, 2022, 7:00
- Finance
- Add a comment
Additional Pharmacodynamic Data on Abelacimab Released at the 2022 Congress of the International Society on Thrombosis and Haemostasis (ISTH) CAMBRIDGE, Mass., July 13, 2022 /PRNewswire/ — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for…
About the Author
adminasapcorp has written 41821 stories on this site.